Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 990 in its research report dated August 05, 2025.

Hold Alembic Pharma: target of Rs 900: ICICI Securities

ICICI Securities recommended hold rating on Alembic Pharma with a target price of Rs 900 in its research report dated August 06, 2025.

Neutral Alembic Pharma; target of Rs 930: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 930 in its research report dated May 06, 2025.

Hold Alembic Pharma: target of Rs 925: ICICI Securities

ICICI Securities recommended hold rating on Alembic Pharma with a target price of Rs 925 in its research report dated February 04, 2025.

Hold Alembic Pharmaceutical; target of Rs 909: KR Choksey

KR Choksey recommended hold rating on Alembic Pharmaceutical with a target price of Rs 909 in its research report dated February 06, 2025.

Neutral Alembic Pharma; target of Rs 970: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 970 in its research report dated February 03, 2025.

Hold Alembic Pharmaceutical; target of Rs 1087: KR Choksey

KR Choksey recommended hold rating on Alembic Pharmaceutical with a target price of Rs 1087 in its research report dated November 08, 2024.

Neutral Alembic Pharma; target of Rs 1110: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1110 in its research report dated November 07, 2024.

Hold Alembic Pharmaceutical; target of Rs 1122: KR Choksey

KR Choksey recommended hold rating on Alembic Pharmaceutical with a target price of Rs 1122 in its research report dated August 13, 2024.

Hold Alembic Pharmaceutical; target of Rs 986: KR Choksey

KR Choksey recommended hold rating on Alembic Pharmaceutical with a target price of Rs 986 in its research report dated May 14, 2024.

Neutral SRF; target of Rs 2,100: Motilal Oswal

Motilal Oswal recommended accumulate rating on SRF with a target price of Rs 2,100 in its research report dated May 09, 2024.

Neutral Alembic Pharma; target of Rs 960: Motilal Oswal

Motilal Oswal recommended accumulate rating on Alembic Pharma with a target price of Rs 960 in its research report dated May 09, 2024.

Neutral Alembic Pharma; target of Rs 710: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 710 in its research report date November 07, 2023.

Reduce Alembic Pharma; target of Rs 705: ICICI Securities

ICICI Securities recommended reduce rating on Alembic Pharma with a target price of Rs 705 in its research report dated August 07, 2023.

Buy Alembic Pharma; target of Rs 704: KR Choksey

KR Choksey is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 704 in its research report dated May 06, 2023.

Neutral Alembic Pharma; target of Rs 550: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 550 in its research report dated May 06, 2023.

Hold Alembic Pharma; target of Rs 550: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 550 in its research report dated February 02, 2023.

Neutral Alembic Pharma; target of Rs 580: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 580 in its research report dated February 01, 2023.

Hold Alembic Pharma; target of Rs 625: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 625 in its research report dated November 14, 2022.

Hold Alembic Pharmaceuticals; target of Rs 758: KR Choksey

KR Choksey recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 758 in its research report date May 05, 2022.

Hold Alembic Pharma; target of Rs 720: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 720 in its research report dated May 04, 2022.

Hold Alembic Pharma: target of Rs 770: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 770 in its research report dated February 11, 2022.

Buy Alembic Pharma; target of Rs 790: ICICI Direct

ICICI Direct is bullish on Alembic Pharma recommended buy rating on the stock with a target price of Rs 790 in its research report dated November 11, 2021.

Hold Alembic Pharmaceuticals; target of Rs 778: KR Choksey

KR Choksey recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 778 in its research report dated November 12, 2021.

Neutral Alembic Pharma; target of Rs 860: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 860 in its research report dated November 11, 2021.